How Tempus AI Built a Defensible Data Moat in Precision Healthcare

As access to powerful general-purpose AI models expands, access alone offers limited differentiation. In precision healthcare, competitive advantage can come from combining proprietary clinical data, specialized models, and integration into diagnostic workflows.

ETF Trends • Oct 22, 2026

How to Invest in AI Drug Discovery

.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.

ETF Trends • Oct 14, 2026

How Healthcare Tech ETF HTEC Defied September's Market Turmoil

It's always exciting to see a fund perform well over the course of a month, but it's also important to understand exactly why that strong performance may be happening. Key Takeaways: September proved to be a relatively difficult month for many sectors of the equity market, including the healthcare sector.

ETF Trends • Oct 5, 2026

The Top HealthTech Questions Landing on Our Desks

Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).

ETF Trends • Sep 30, 2026

AI & Robotics in 2026: 16 Recent Developments for Investors

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper inference, AI systems reaching into laboratories and physical equipment, robots learning from fewer demonstrations, and new capital and infrastructure forming around commercial deployment.

ETF Trends • Sep 9, 2026

Why Moderna's Cancer Vaccine Matters to Investors

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.

ETF Trends • Sep 2, 2026

Cyclosporiasis: Investing in Biosecurity

In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability. Since May, an ongoing cyclosporiasis outbreak that may be linked to contaminated Mexican iceberg lettuce has caused over 1,600 confirmed cases and prompted multi-state recalls.

ETF Trends • Jul 22, 2026

Why Pure-Play Healthcare Technology Innovation Matters

Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides targeted exposure to the global value chain driving this high-growth opportunity.

ETF Trends • Jul 6, 2026

HTEC Opens Canada's First 700 Bar Commercial Heavy-Duty Clean Hydrogen Station

Station on Tsawwassen First Nation land in British Columbia marks a key milestone for the deployment of hydrogen-powered trucks Station on Tsawwassen First Nation land in British Columbia marks a key milestone for the deployment of hydrogen-powered trucks

GlobeNewsWire • Jun 18, 2026

Industrial ETFs: Riding the Physical AI Supercycle

Investors once shrugged off industrials as slow-growth cyclical businesses that lagged tech at every turn. But the AI boom has driven a significant re-rating of the sector.

ETF Trends • Jun 3, 2026